Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
bordetella pertussis toxoid antigen (formaldehyde inactivated)
- Development stage
- Approved
- Lead developer
- Sanofi Pasteur
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Bordetella pertussis toxoid antigen (formaldehyde inactivated) is a vaccine component used in the prophylaxis of pertussis (whooping cough), a respiratory disease caused by the bacterium Bordetella pertussis. The antigen is derived from the pertussis toxin that has been detoxified using formaldehyde, which eliminates its toxicity while preserving its ability to stimulate an immune response. This component is typically included in combination vaccines such as DTaP (Diphtheria, Tetanus, acellular Pertussis) and Tdap vaccines. It works by inducing actively acquired immunity against pertussis.
- Brand names
- Vaxelis
- Other names
- Bordetella pertussis toxoid antigen, CN51SPD4A45N-51SPD4A45N 51SPD4A45
Beyond the preview
Go deeper on bordetella pertussis toxoid antigen (formaldehyde inactivated).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on bordetella pertussis toxoid antigen (formaldehyde inactivated).